Purchases and Sales Made in Q4 2024 in Atai Life Sciences N.V. (ATAI)
This table provides information about the institutional ownership of Atai Life Sciences N.V. (ATAI) during Q4 2024. The information is specifically focused on institutions that hold shares of ATAI Life Sciences N.V..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jan 13, 2025
Q4 2024
|
Wedmont Private Capital
|
SELL
|
- |
-2K- 7.41% |
$2.12K - $3.56K
|
25K
$68.8K
|
|
|
Feb 12, 2025
Q4 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-3.42K- 20.29% |
$3.62K - $6.09K
|
13.4K
$36.9K
|
|
|
Feb 11, 2025
Q4 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-7.12K- 1.75% |
$7.55K - $12.7K
|
401K
$1.1M
|
|
|
Feb 14, 2025
Q4 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-16.3K- 4.0% |
$17.3K - $29K
|
391K
$1.07M
|
|
|
Jun 06, 2025
Q4 2024
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-23.7K- 87.29% |
$25.1K - $42.2K
|
3.45K
$9.49K
|
|
|
Feb 14, 2025
Q4 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-40.7K- 82.22% |
$43.2K - $72.5K
|
8.81K
$24.2K
|
|
|
Feb 13, 2025
Q4 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-81.6K- 33.09% |
$86.5K - $145K
|
165K
$454K
|